Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...

Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...

Good morning, and welcome to the Boston Scientific Fourth Quarter ... the quarter and low single digits for the year. Within deep brain stimulation, we expect improving growth in 2025 with the ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Boston Scientific BSX is slated to report ... which is designed to improve the precision and efficiency of the deep brain stimulation procedure. BSX stock is not so cheap as its Value Score ...

Leading players in the neurostimulation devices market include Medtronic, Boston Scientific, Abbott, LivaNova, NEVRO, and BrainsWay. The Infinity DBS system from Abbott integrates directional leads ...

This month, our guest speaker will be Alexander Francis. Mr. Francis is a Clinical Specialist with Boston Scientific DBS. He supports Neurologists and Neurosurgeons during and after the DBS ...